EDTUTC-4 New YorkLog in Sign up

KHTRF
KNIGHT THERAPEUTICS INC
stockOTC

EODSep 30, 2026

7.47USD+3.177%(+0.23)2,171

KHTRF News

Day breaks

06:14 AM EDTKyowa Kirin y Knight Therapeutics firman un acuerdo exclusivo para distribuir POTELIGEO® (mogamulizumab) a pacientes con linfoma cutáneo de células T en América Latina ·

Business Wire

03:36 AM EDTKyowa Kirin, Knight agree Latin American distribution deal for mogamulizumab ·

Pharmaceutical Technology

09:02 AM EDTKyowa Kirin, Knight Therapeutics Enter Distribution Deal For POTELIGEO In Latin America ·

RTTNews

07:52 AM EDTKnight Therapeutics Enters into Exclusive Distribution Agreement with Kyowa Kirin International for Poteligeo® (Mogamulizumab) ·

Financial Post

07:30 AM EDTKnight Therapeutics Enters into Exclusive Distribution Agreement with Kyowa Kirin International for Poteligeo® (Mogamulizumab) ·

GlobeNewswire Inc.

10:00 AM EDTKnight Therapeutics Inc. places No. 345 on The Globe and Mail’s eighth annual ranking of Canada’s Top Growing Companies ·

Financial Post

09:55 AM EDTKnight Therapeutics Inc. places No. 345 on The Globe and Mail’s eighth annual ranking of Canada's Top Growing Companies ·

GlobeNewswire Inc.

09:46 AM EDTKnight Therapeutics Announces Regulatory Submission of GEMTESA® in Canada ·

BNN Bloomberg

07:30 AM EDTKnight Therapeutics Announces Regulatory Submission of GEMTESA® in Canada ·

GlobeNewswire Inc.

06:00 PM EDTKnight Therapeutics Announces Regulatory Approval of TAVALISSE® in Colombia ·

GlobeNewswire Inc.

06:00 PM EDTThérapeutique Knight annonce l’approbation réglementaire de TAVALISSE® en Colombie ·

GlobeNewswire Inc.